Worldquant Millennium Advisors LLC Biomarin Pharmaceutical Inc Transaction History

Worldquant Millennium Advisors LLC

$10.9 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $12.5 Million - $16.8 Million	-154,461 Reduced 87.1%	22,872 $2.37 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $7.58 Million - $8.95 Million	92,275 Added 108.48%	177,333 $15 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $4.31 Million - $5.23 Million	60,231 Added 242.6%	85,058 $7.05 Million
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $2.6 Million - $3.25 Million	-35,024 Reduced 58.52%	24,827 $1.91 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $1.66 Million - $2.12 Million	-23,150 Reduced 27.89%	59,851 $5.29 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $6.21 Million - $7.09 Million	83,001 New	83,001 $6.42 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $2.38 Million - $2.95 Million	-32,717 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $4.23 Million - $7.72 Million	-58,915 Reduced 64.3%	32,717 $2.49 Million
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $938,928 - $1.47 Million	-11,803 Reduced 11.41%	91,632 $11.3 Million
Q1 2020 May 14, 2020	BUY	$71.37 - $96.85 $196,909 - $267,209	2,759 Added 2.74%	103,435 $8.74 Million
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $1.27 Million - $1.71 Million	-19,771 Reduced 16.41%	100,676 $8.51 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $785,749 - $992,212	-11,658 Reduced 8.82%	120,447 $8.12 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $1.56 Million - $1.82 Million	19,398 Added 17.21%	132,105 $11.3 Million
Q1 2019 May 14, 2019	SELL	$84.2 - $98.62 $2.87 Million - $3.36 Million	-34,064 Reduced 23.21%	112,707 $10 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $2.61 Million - $3.45 Million	-32,523 Reduced 18.14%	146,771 $12.5 Million
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $3.71 Million - $4.18 Million	39,532 Added 28.29%	179,294 $17.4 Million
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $10.6 Million - $13.8 Million	139,762 New	139,762 $13.2 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.

Account